Association between chronic colonization or infection with Pseudomonas aeruginosa and bronchial hyperreactivity in patients with cystic fibrosis;Asociación entre colonización-infección crónica por Pseudomonas aeruginosa e hiperreactividad bronquial en pacientes con fibrosis quística

Archivos de Bronconeumologia

Volumn 44, Issue 4, 2008, Pages 180-184

  Valverde Molina, José ^a   Sánchez Solís, Manuel ^b,c   Pastor Vivero, María Dolores ^b   García Marcos, Luis ^c  

^a Hospital Los Arcos   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

Atopy; Bronchial hyperreactivity; Cystic fibrosis; Pseudomonas aeruginosa

Indexed keywords

HISTAMINE;

ARTICLE; ATOPY; BACTERIAL COLONIZATION; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INHALATION TEST; LUNG FUNCTION; MALE; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 45549102327     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13119536     Document Type: Article

References (35)

1. Dinwiddie R. Pathogenesis of lung disease in cystic fibrosis. Respiration. 2000;67:3-8.
2. Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J. 2001;18:298-305.
3. Halfhide C, Evans H, Couriel J. Inhaled bronchodilators for cystic fibrosis. Cochrane Database Syst Rev. 2005;4:CD003428.
4. Koch C, McKenzie SG, Kaplowitz H, Hodson ME, Harms HK, Navarro J, et al. International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF). Pediatr Pulmonol. 1997;24:147-54.
5. Balfour-Lynn IM, Elborn JS. "CF asthma": what is it and what do we do about it? Thorax. 2002;57:742-8.
6. de Rose V. Mechanisms and markers of airway inflammation in cystic fibrosis. Eur Respir J. 2002;19:333-40.
7. Khan TZ, Wagener JS, Bost T, Martínez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151:1075-82.
8. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ. 1995;310:1571-2.
9. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol. 1995;20:63-70.
10. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J. 1998;12:1290-4.
11. Marguet C, Jouen-Boedes F, Dean TP, Warner JO. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis. Am J Respir Crit Care Med. 1999;159: 1533-40.
12. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000;161:9-16.
13. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Hoiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS. 2000;108:329-35.
14. Weinberger M. Airways reactivity in patients with CF. Clin Rev Allergy Immunol. 2002;23:77-85.
15. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235-43.
16. Cantón R, Cobos N, De Gracia J, Baquero F, Honorato J, Gartner S, et al, en representación del Grupo Español de Consenso del Tratamiento Antimicrobiano en el Paciente con Fibrosis Quística. Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística. Arch Bronconeumol. 2005;41 Supl 1:1-25.
17. Mellis CM, Levison H. Bronchial reactivity in cystic fibrosis. Pediatrics. 1978;61:446-50.
18. Tobin MJ, Maguire O, Reen D, Tempany E, Fitzgerald MX. Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax. 1980;35:807-13.
19. Mitchell I, Corey M, Woenne R, Krastins IR, Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr. 1978;93:744-8.
20. Eggleston PA, Rosenstein BJ, Stackhouse CM, Alexander MF. Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease. Chest. 1988;94:360-5.
21. Sánchez I, Powell RE, Chernick V. Response to inhaled bronchodilators and nonspecific airway hyperreactivity in children with cystic fibrosis. Pediatr Pulmonol. 1992;14:52-7.
22. van Asperen P, Mellis CM, South RT, Simpson SJ. Bronchial reactivity in cystic fibrosis with normal pulmonary function. Am J Dis Child. 1981;135:815-9.
23. Macfarlane PI, Heaf D. Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis. Pediatr Pulmonol. 1990;8:4-11.
24. Rodwell LT, Anderson SD. Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis: a pilot study. Pediatr Pulmonol. 1996;21:282-9.
25. Zach MS, Oberwaldner B, Forche G, Polgar G. Bronchodilators increase airway instability in cystic fibrosis. Am Rev Respir Dis. 1985;131:537-43.
26. García-Marcos L, Castro-Rodríguez JA, Suárez-Varela MM, Garrido JB, Hernández GG, Gimeno AM, et al. A different pattern of risk factors for atopic and non-atopic wheezing in 9-12-year-old children. Pediatr Allergy Immunol. 2005;16:471-7.
27. Warner JO, Kilburn SA. Cystic fibrosis and allergy. Pediatr Allergy Immunol. 1996;7:67-9.
28. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. δF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet. 1998;351:1911-3.
29. Lázaro C, De Cid R, Sunyer J, Soriano J, Giménez J, Álvarez M, et al. Missense mutations in the cystic fibrosis gene in adult patients with asthma. Hum Mutat. 1999;14:510-9.
30. Bush A, Tiddens H, Silverman M. Clinical implications of inflammation in young children. Am J Respir Crit Care Med. 2000;162:S11-S4.
31. Najafi N, Demanet C, Dab I, de Waele M, Malfroot A. Differential cytology of bronchoalveolar lavage fluid in asthmatic children. Pediatr Pulmonol. 2003;35:302-8.
32. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54-61.
33. Sala A, Folco G. Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation? Biochem Biophys Res Commun. 2001;283:1003-6.
34. Hays SR, Ferrando RE, Carter R, Wong HH, Woodruff PG. Structural changes to airway smooth muscle in cystic fibrosis. Thorax. 2005;60:226-8.
35. Coulson FR, Fryer AD. Muscarinic acetylcholine receptors and airway diseases. Pharmacol Ther. 2003;98:59-69